Therapeutic ingenuity.
It’s in our blood.

Patients inspire our drive to develop ground-breaking medicines for life-threatening, blood-related disorders.

Following Where the Science Leads

We have a spirit of exploration that is driven by one objective: transforming how patients with serious blood-related disorders are treated.

This singular purpose has yielded a portfolio of novel medicines, including 2 US FDA-approved products that are the first and only of their kind in treating blood-related disorders. From discovery to commercialization, our team pioneers new approaches in the fields of thrombosis and other hematologic disorders.